- Home
- PROK vs ITRG Comparison
PROK vs ITRG Comparison
Compare PROK & ITRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PROK | ITRG |
|---|---|---|
| Founded | 2015 | 1997 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 417.1M | 482.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | PROK | ITRG |
|---|---|---|
| Price | $2.26 | $3.69 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | ★ $6.25 | $4.00 |
| AVG Volume (30 Days) | 1.4M | ★ 2.3M |
| Earning Date | 11-10-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.08 |
| Revenue | $744,000.00 | ★ $219,125,000.00 |
| Revenue This Year | $918.66 | $709.65 |
| Revenue Next Year | N/A | $36.86 |
| P/E Ratio | ★ N/A | $46.27 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.46 | $0.79 |
| 52 Week High | $7.13 | $3.80 |
Technical Indicators
Market Signals| Indicator | PROK | ITRG |
|---|---|---|
| Relative Strength Index (RSI) | 41.28 | 68.35 |
| Support Level | $2.04 | $2.73 |
| Resistance Level | $2.25 | $3.80 |
| Average True Range (ATR) | 0.20 | 0.20 |
| MACD | -0.00 | 0.08 |
| Stochastic Oscillator | 26.19 | 90.13 |
Price Performance
Historical ComparisonAbout PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.
About ITRG Integra Resources Corp.
Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of prospective early-stage exploration projects in Idaho, Nevada, and Arizona.